Thomas Klein

6PUBLICATIONS
17CO-AUTHORS
Molecular targetsCharacterisation of biological macromoleculesBiomolecular modelling and designClinical pharmacology and therapeuticsMolecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 15, 2025
Pre-stroke weight loss by glucagon-like peptide 1 receptor and neuropeptide Y receptor Y2 activation improves post-stroke functional recovery in male diabetic mouse models.

Ellen Vercalsteren, Dimitra Karampatsi, Maria Neicu

|Apr 21, 2021
Urinary dipeptidyl peptidase-4 protein is increased by linagliptin and is a potential predictive marker of urine albumin-to-creatinine ratio reduction in patients with type 2 diabetes.

Thomas Klein, Harald Tammen, Michael Mark

|Dec 21, 2020
Action of Dipeptidyl Peptidase-4 Inhibitors on SARS-CoV-2 Main Protease.

Herbert Nar, Gisela Schnapp, Oliver Hucke

|Oct 08, 2020
A Single Second Shell Amino Acid Determines Affinity and Kinetics of Linagliptin Binding to Type 4 Dipeptidyl Peptidase and Fibroblast Activation Protein.

Gisela Schnapp, Yvette Hoevels, Remko A Bakker

|Feb 17, 2015
Prostacyclin synthase: upregulation during renal development and in glomerular disease as well as its constitutive expression in cultured human mesangial cells.

Thomas Klein, Günther Klaus, Martin Kömhoff

Pageof 1

Frequent Collaborators

2 joint publications

Gisela Schnapp

2 joint publications

Herbert Nar

1 joint publications

Martin Kömhoff

1 joint publications

Yvette Hoevels